• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    Translating disease-related findings

    While John Blenis, PhD (HMS), a cell biologist and biochemist interested in cancer cell metabolism, works at the basic science level, he collaborates with pre-clinical researchers

    Cell Manipulation Core Facility

    The Cell Manipulation Core Facility (CMCF) produces safe and effective cellular components for subjects enrolled in novel therapeutic clinical research protocols

    Eleven new members join DF/HCC

    Eleven individuals have recently joined DF/HCC

    DF/HCC-led trials aim to overcome resistance in metastatic GIST

    Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract

    Cells to Society: New centers explore two major areas of cancer disparities

    The earlier onset, higher rates, and worse outcomes of cancer in poor and minority populations in the United States may be well documented, but they are not well understood

    Major study tests primary prevention power of vitamin D and omega-3s

    Television news and cereal boxes tout the health benefits of extra vitamin D and omega-3 fatty acids, but exceeding the recommended dietary allowance of either is not a proven way to prevent cancer nor cardiovascular di

    Phase II study tests exercise, metformin in colorectal cancer survivors

    Nearly 150,000 people are diagnosed with colorectal cancer every year in the United States, leading to approximately 50,000 deaths from the disease

Displaying results 50 to 56 out of 206